Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641172-25-024020
Filing Date
2025-08-14
Accepted
2025-08-14 16:08:03
Documents
67
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 1306557
2 EX-10.1 ex10-1.htm EX-10.1 152115
3 EX-10.2 ex10-2.htm EX-10.2 265819
4 EX-31.1 ex31-1.htm EX-31.1 16927
5 EX-31.2 ex31-2.htm EX-31.2 16936
6 EX-32.1 ex32-1.htm EX-32.1 8274
7 EX-32.2 ex32-2.htm EX-32.2 8139
  Complete submission text file 0001641172-25-024020.txt   6264109

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE rnxt-20250630.xsd EX-101.SCH 38228
9 XBRL CALCULATION FILE rnxt-20250630_cal.xml EX-101.CAL 48169
10 XBRL DEFINITION FILE rnxt-20250630_def.xml EX-101.DEF 145393
11 XBRL LABEL FILE rnxt-20250630_lab.xml EX-101.LAB 329755
12 XBRL PRESENTATION FILE rnxt-20250630_pre.xml EX-101.PRE 256114
69 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 934313
Mailing Address 2570 W. EL CAMINO REAL, STE. 320, MOUNTAIN VIEW CA 94040
Business Address 2570 W. EL CAMINO REAL, STE. 320, MOUNTAIN VIEW CA 94040 408-800-2649
RenovoRx, Inc. (Filer) CIK: 0001574094 (see all company filings)

EIN.: 271448452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40738 | Film No.: 251218940
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)